Literature DB >> 32292678

The Relationship Between Polypharmacy and Hospital-stay Duration: A Retrospective Study.

Nobuhiko Fukuba1, Mutsuko Nishida2, Miki Hayashi2, Natsuko Furukawa2, Hitomi Ishitobi1, Makoto Nagaoka1, Yoshiko Takahashi1, Hiroyuki Fukuhara1, Mika Yuki1, Yoshinori Komazawa1, Shuichi Sato1, Toshihiro Shizuku1.   

Abstract

Background There have been very few studies on the association of polypharmacy with clinical course. In this paper, we seek to evaluate the relationship between polypharmacy and hospitalization period. Methods We retrospectively analyzed 322 patients hospitalized from February to September 2017, after excluding short-term and orthopedic cases. Patients with polypharmacy were defined as those who were prescribed more than five drugs at the time of admission. The primary endpoint for all subjects regardless of polypharmacy was the hospitalization period. Using Mann-Whitney U test results, we compared the average number of hospital days between patients with and without polypharmacy. Secondary endpoints were hospitalization period with and without polypharmacy for each disease type. Results The hospitalization period was significantly extended for patients with polypharmacy as compared to those without (31.6 vs. 23.2 days, p: 0.002). Those with an infection had significantly longer hospitalization than those without polypharmacy (27.6 vs. 18.1 days, p: 0.007). Malignancy, heart disease, and cerebrovascular disease did not have a significant effect on hospitalization regardless of polypharmacy. Conclusion Polypharmacy is related to an extended hospitalization period and is found to occur more frequently in patients hospitalized for an infection.
Copyright © 2020, Fukuba et al.

Entities:  

Keywords:  hospital stay period; infection; polypharmacy

Year:  2020        PMID: 32292678      PMCID: PMC7153814          DOI: 10.7759/cureus.7267

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  4 in total

1.  Risk factors for adverse drug events among nursing home residents.

Authors:  T S Field; J H Gurwitz; J Avorn; D McCormick; S Jain; M Eckler; M Benser; D W Bates
Journal:  Arch Intern Med       Date:  2001-07-09

2.  Pharmacokinetics and pharmacodynamic changes associated with aging and implications for drug therapy.

Authors:  Leah Church Sera; Mary Lynn McPherson
Journal:  Clin Geriatr Med       Date:  2012-05       Impact factor: 3.076

3.  Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study.

Authors:  Sinem Ezgi Gulmez; Anette Holm; Henrik Frederiksen; Thøger Gorm Jensen; Court Pedersen; Jesper Hallas
Journal:  Arch Intern Med       Date:  2007-05-14

4.  A hospital study of community acquired pneumonia in the elderly.

Authors:  P Venkatesan; J Gladman; J T Macfarlane; D Barer; P Berman; W Kinnear; R G Finch
Journal:  Thorax       Date:  1990-04       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.